These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 7754438
1. [Incidence, clinico-biological characteristics, and clinical course of 1,203 monoclonal gammopathies (1971-1992)]. Giraldo P, Rubio-Félix D, Cortés T, Delgado P, Franco E, Gimeno J, Tapia M, Giralt M. Sangre (Barc); 1994 Oct; 39(5):343-50. PubMed ID: 7754438 [Abstract] [Full Text] [Related]
8. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance. Rossi F, Petrucci MT, Guffanti A, Marcheselli L, Rossi D, Callea V, Vincenzo F, De Muro M, Baraldi A, Villani O, Musto P, Bacigalupo A, Gaidano G, Avvisati G, Goldaniga M, Depaoli L, Baldini L. Clin Cancer Res; 2009 Jul 01; 15(13):4439-45. PubMed ID: 19509142 [Abstract] [Full Text] [Related]
9. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Gregersen H, Mellemkjaer L, Ibsen JS, Dahlerup JF, Thomassen L, Sørensen HT. Haematologica; 2001 Nov 01; 86(11):1172-9. PubMed ID: 11694403 [Abstract] [Full Text] [Related]
11. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital]. Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M. Rinsho Byori; 2004 Jul 01; 52(7):574-9. PubMed ID: 15344556 [Abstract] [Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS. Oncologist; 1996 Jul 01; 1(5):326-330. PubMed ID: 10388011 [Abstract] [Full Text] [Related]
13. [Monoclonal gammapathy of undetermined significance and autoimmune disease: description of three cases in Senegal]. Diallo S, Ndiaye FS, Pouye A, Lèye A, Touré MA, Diop S, Dièye T, Ka MM, Thiam D, Diakhaté L, Diop TM. Med Trop (Mars); 2008 Feb 01; 68(1):65-8. PubMed ID: 18478776 [Abstract] [Full Text] [Related]
14. Long-term follow-up of a population based cohort with monoclonal proteinaemia. Schaar CG, le Cessie S, Snijder S, Franck PF, Wijermans PW, Ong C, Kluin-Nelemans H. Br J Haematol; 2009 Jan 01; 144(2):176-84. PubMed ID: 19036113 [Abstract] [Full Text] [Related]
16. [Rapid development of primary amyloidosis after two years' follow-up of monoclonal gammopathy of undetermined significance (MGUS)]. Kanoh T, Inoue M, Okuma M. Rinsho Ketsueki; 1993 Aug 01; 34(8):952-6. PubMed ID: 8411650 [Abstract] [Full Text] [Related]
18. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G. Clin Cancer Res; 2005 Mar 01; 11(5):1786-90. PubMed ID: 15756000 [Abstract] [Full Text] [Related]
19. [Tuberculosis in compromised hosts]. Kekkaku; 2003 Nov 01; 78(11):717-22. PubMed ID: 14672050 [Abstract] [Full Text] [Related]
20. [Monoclonal gammopathies of undetermined significance]. Krizalkovicová V, Maisnar V, Pour L, Radocha J, Hájek R. Klin Onkol; 2008 Nov 01; 21(4):160-4. PubMed ID: 19102222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]